Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Fish and Richardson
Merck
Boehringer Ingelheim
UBS
Johnson and Johnson
Queensland Health
US Army
Farmers Insurance

Generated: January 17, 2019

DrugPatentWatch Database Preview

Cefixime - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cefixime and what is the scope of cefixime freedom to operate?

Cefixime is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Lupin Ltd, Aurobindo Pharma Ltd, Belcher Pharms Llc, Sandoz Inc, Lederle, and Lupin Pharms, and is included in thirteen NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Cefixime has two patent family members in two countries.

There are fourteen drug master file entries for cefixime. Nine suppliers are listed for this compound.

Pharmacology for cefixime
Medical Subject Heading (MeSH) Categories for cefixime
Synonyms for cefixime
(-)-Cefixim
(6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-((carboxymethoxy)imino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-(carboxymethyl)oxime) trihydrate
(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-(carboxymethyl)oxime)trihydrate
(6r,7r)-7-[-2-(2-amino-thiazol-4-yl)-2-carboxymethoxyimino-acetylamino]-8-oxo-3-vinyl-5-thia-1-aza-b
(6R,7R)-7-[-2-(2-Amino-thiazol-4-yl)-2-carboxymethoxyimino-acetylamino]-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4. 2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethyloxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
(6R,7R)-7-[[(2z)-2-(2-amino-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]Oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(carboxymethyl)oxy]imino}acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
214265-67-5
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)((carboxymethoxy)imino)acetyl)amino)-3-ethenyl-8-oxo-, trihydrate, (6R-(6alpha,7beta(Z)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2Z)-(2-amino-4-thiazolyl)((carboxymethoxy)imino)acetyl)amino)-3-ethenyl-8-oxo-, (6R,7R)-
50C371
79350-37-1
7beta-{(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido}-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid
AB00513842
AB0073052
AC-4350
AC1NSFNI
AK326220
AKOS015854940
AKOS015961135
AT-7061
BC205782
BDBM84007
BPBio1_000622
BRD-K71059170-001-02-5
BRN 6025058
BSPBio_000564
C04
C06881
CCG-220462
Cefixim
Cefixima
Cefixima [Spanish]
Cefixime (JAN/USP/INN)
Cefixime (JP15/USP/INN)
Cefixime [USAN:USP:INN:BAN:JAN]
Cefixime Anhydrous
Cefixime EP Impurity C (Cefixime 7-epimer)
Cefixime, Antibiotic for Culture Media Use Only
Cefixime(7-[[(2-amino-4-thiazolgl)(Carboxymethoxg)imino]acetyl]amino-3-vinyl -8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-Carboxylicacidtrihydrate)
cefiximine
Cefiximum
Cefiximum [Latin]
Cefixoral
Cefspan
Cephoral
CFIX
CHEBI:472657
CHEMBL1541
cid_5362065
CL 284,635
CL-284635
CS-4820
D00258
D06OVY
DB00671
Denvar
FK-027
FR- 17027
FR-17027
HE325243
HMS2096M06
HMS2234J21
HY-B1381
LS-187248
MFCD00865020
MLS002222332
MolPort-003-845-687
NCGC00179521-01
Necopen
Ofex (TN)
Prestwick3_000462
PubChem13762
RS0002
s4596
SCHEMBL24945
SMR001307271
Suprax
Suprax (TN)
TC-070894
Tricef
UNII-XZ7BG04GJX
Unixime
X-2622
XZ7BG04GJX
ZINC12503147

US Patents and Regulatory Information for cefixime

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd SUPRAX cefixime TABLET, CHEWABLE;ORAL 065380-002 Oct 25, 2010 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alkem Labs Ltd CEFIXIME cefixime CAPSULE;ORAL 210574-001 Oct 9, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lupin Ltd SUPRAX cefixime TABLET, CHEWABLE;ORAL 065380-001 Oct 25, 2010 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lupin Pharms SUPRAX cefixime FOR SUSPENSION;ORAL 065355-001 Apr 10, 2007 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz Inc CEFIXIME cefixime FOR SUSPENSION;ORAL 206144-002 Nov 17, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Belcher Pharms Llc CEFIXIME cefixime FOR SUSPENSION;ORAL 206939-001 Feb 6, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lupin Ltd SUPRAX cefixime FOR SUSPENSION;ORAL 202091-001 Feb 20, 2013 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Citi
Covington
Medtronic
Baxter
Farmers Insurance
Johnson and Johnson
Cantor Fitzgerald
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.